Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Enteral Syringe Market to grow by USD 355.15 mn |35% of Growth to Originate from North America from 2020 to 2025 | 17000+ Technavio Research Reports


NEW YORK, Dec. 6, 2021 /PRNewswire/ -- The "Enteral Syringe Market by Product (disposable syringes and reusable syringes) and Geography (North America, Europe, Asia, and ROW) - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years. The potential growth difference for the enteral syringe market between 2020 and 2025 is USD 355.15  million.

To get the exact yearly growth variance and the Y-O-Y growth rate -Talk to our analyst.

Key Regions & Revenue Generating Segment

The enteral syringe market report is segmented by Product (disposable syringes and reusable syringes) and Geography (North America, Europe, Asia, and ROW).  North America will be the leading region with 35% of the market's growth. The US and Canada are the key markets for enteral syringes in the region. Factors such as the increasing prevalence of chronic conditions such as cancer, the rising number of product launches with technological advances, the growing presence of regional and global vendors, and initiatives by government and non-profit organizations for creating awareness about enteral feeding will facilitate the enteral syringe market growth in North America.

The enteral syringe market share growth by the disposable syringes segment will be significant for revenue generation. Factors such as updates in regulatory guidelines for manufacturing enteral devices to provide safe enteral feeding, and preference for disposable syringes over reusable syringes, owing to the growing concern of infections in patients, are driving the growth of the disposable syringes segment

View our sample report for additional insights into the contribution of all the segments, and regional opportunities in the report.

Key Market Dynamics:

The increasing prevalence of critical care conditions and upcoming business strategies are some of the key market drivers. However, factors such as safety concerns related to enteral feeding will challenge market growth.

To learn about additional key drivers, trends, and challenges available with TechnavioRead our FREE Sample Report right now!

Some Companies Mentioned       

Related Reports:
Pre-filled Syringes Market -
The prefilled syringes market size has the potential to grow by USD 4.23 billion during 2020-2024. However, the market's growth momentum will decelerate during the forecast period. Download a free sample now!

Injection Pen Market -The injection pen market share should rise by USD 17.67 billion from 2021 to 2025 at a CAGR of 7.40%. Download a free sample now!

Enteral Syringe Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of over 5.43%

Market growth 2021-2025

USD 355.15 million

Market structure

Fragmented

YoY growth (%)

4.15

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 35%

Key consumer countries

US, Germany, Canada, China, UK, and India

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Amsino International Inc., Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., GBUK Group Ltd., Medela AG, Terumo Corp., and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Key Topics Covered:

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...

16 mai 2024
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...



News published on and distributed by: